statin
lower
hyperlipidemia
reduc
incid
cardiovascular
event
relat
mortal
man
diagnos
transient
ischem
attack
start
acetyllcarnitin
cilostazol
rosuvastatin
rosuvastatin
treatment
week
patient
present
sudden
onset
fever
cough
dyspnea
symptom
aggrav
despit
empir
antibiot
treatment
infecti
pathogen
exclud
base
result
cultur
polymeras
chain
reaction
bronchoscop
wash
specimen
chest
radiographi
show
diffus
groundglass
opac
lung
along
sever
subpleur
groundglass
opac
nodul
foami
alveolar
macrophag
appear
confirm
bronchoalveolar
lavag
suspect
rosuvastatininduc
lung
injuri
discontinu
rosuvastatin
initi
prednisolon
mgkg
taper
initi
steroid
therapi
symptom
radiolog
find
significantli
improv
suggest
clinician
awar
potenti
rosuvastatininduc
lung
injuri
statin
hydroxymethylglutaryl
coa
reductas
inhibitor
known
lower
plasma
lowdens
lipoprotein
ldl
cholesterol
level
reduc
incid
cardiovascular
event
mortal
current
avail
statin
includ
lovastatin
pravastatin
simvastatin
fluvastatin
atorvastatin
tuberc
respir
di
wwwetrdorg
old
wallpap
time
caus
remov
recur
year
also
administ
metformin
mg
daili
month
diabet
mellitu
transient
ischem
attack
secondari
vertebr
arteri
stenosi
hospit
start
acetyllcarnitin
cilostazol
rosuvastatin
accord
follow
schedul
acetyllcarnitin
mg
daili
day
prior
hospit
cilostazol
mg
twice
daili
rosuvastatin
mg
daili
day
prior
hospit
continu
medic
develop
fever
cough
day
prior
hospit
visit
although
prescrib
antibiot
augmentin
day
local
clinic
dyspnea
cough
fever
gradual
increas
refer
hospit
proper
evalu
manag
known
drug
allergi
upon
admiss
patient
vital
sign
follow
blood
pressur
mm
hg
puls
beat
per
minut
respiratori
rate
breath
per
minut
bodi
temperatur
c
physic
examin
coars
breath
sound
fine
crackl
without
wheez
heard
upon
auscult
lung
patient
laboratori
test
result
follow
hemoglobin
gdl
white
blood
cell
count
neutrophil
lymphocyt
monocyt
eosinophil
basophil
platelet
count
patient
serum
biochemistri
test
result
reveal
follow
aspart
aminotransferas
iul
alanin
aminotransferas
iul
total
bilirubin
mgdl
alkalin
phosphatas
iul
total
protein
gdl
albumin
gdl
blood
urea
nitrogen
mg
dl
creatinin
mgdl
total
cholesterol
mgdl
creactiv
protein
mgdl
ldl
cholesterol
mgdl
coagul
profil
within
normal
limit
urinalysi
microscopi
clear
arteri
blood
ga
analysi
fraction
inspir
oxygen
fio
conduct
patient
breath
room
air
reveal
follow
ph
partial
pressur
oxygen
pao
mm
hg
partial
pressur
carbon
dioxid
paco
mm
hg
bicarbon
hco
meql
satur
level
oxygen
sao
chest
radiograph
show
subtl
diffus
groundglass
opac
lower
lung
field
subsegment
atelectasi
left
lower
lobe
chest
comput
tomographi
scan
reveal
diffus
illdefin
groundglass
opac
septal
line
thicken
bilater
combin
sever
subpleur
groundglass
opac
nodul
figur
pulmonari
function
test
reveal
follow
forc
expiratori
volum
second
fev
forc
vital
capac
fvc
ratio
figur
ae
chest
radiographi
show
subtl
diffus
ground
glass
opac
lower
lobe
field
subsegment
atelectasi
left
lower
lobe
field
admiss
comput
tomographi
scan
chest
show
diffus
illdefin
ground
glass
opac
septal
line
thicken
bilater
lung
field
combin
sever
subpleur
ground
glass
opac
nodul
admiss
wwwetrdorg
fev
l
fvc
l
diffus
capac
carbon
monoxid
dlco
base
past
medic
histori
clinic
symptom
laboratori
find
diagnosi
dild
suspect
consequ
bronchoscopi
bronchoalveolar
lavag
bal
perform
endobronchi
lesion
reveal
bronchoscopi
bal
fluid
result
follow
white
blood
cell
count
neutrophil
lymphocyt
macrophag
eosinophil
basophil
red
blood
cell
count
microbiolog
cultur
polymeras
chain
reaction
bronchoscop
wash
specimen
neg
mycobacterium
tuberculosi
pneumococcu
respiratori
viru
realtim
polymeras
chain
reaction
bronchial
wash
specimen
perform
follow
mycoplasma
chlamydia
legionella
bordetella
haemophilu
pneumonia
adenoviru
rhinoviru
coronaviru
influenza
viru
b
parainfluenza
viru
respiratori
syncyti
viru
b
bocaviru
metapneumoviru
result
neg
addit
urin
antigen
immunolog
studi
perform
exclud
other
pathogen
result
reveal
follow
streptococc
pneumonia
legionella
urinari
antigen
neg
mycoplasma
pneumonia
iggigm
neg
chlamydia
pneumonia
igg
posit
normal
rang
index
igm
neg
normal
rang
index
accord
cytolog
major
alveolar
macrophag
foami
appear
figur
make
differenti
diagnosi
connect
diseas
allerg
diseas
immunolog
studi
multipl
allergosorb
test
system
mast
perform
follow
allergen
mast
class
iuml
rheumatoid
factor
neg
complement
mgdl
normal
rang
mg
dl
complement
mgdl
normal
rang
mg
dl
antinuclear
antibodi
antineutrophil
cytoplasm
antibodi
neg
consid
previou
report
past
drug
histori
rosuvastatin
strongli
suspect
caus
patient
dild
thu
rosuvastatin
discontinu
steroid
therapi
prednisolon
mgkg
bodi
weight
initi
steroid
therapi
patient
symptom
improv
prednisolon
dose
gradual
taper
week
two
week
later
patient
complet
remiss
accord
chest
radiograph
previous
note
diffus
groundglass
opac
lung
field
disappear
figur
statin
indic
treatment
hyperlipidemia
prevent
cardiovascular
event
patient
multipl
risk
factor
although
statin
appear
safe
well
toler
clinic
statin
low
frequenc
side
effect
includ
hepatotox
myotox
proteinuria
howev
advers
reaction
involv
respiratori
system
uncommon
sever
pulmonari
toxic
case
secondari
statin
report
preval
statininduc
interstiti
pneumon
sili
mainli
associ
simvastatin
fluvastatin
atorvastatin
high
rosuvastatininduc
interstiti
pneumon
rare
report
knowledg
case
taiwan
case
unit
state
report
addit
rosuvastatininduc
interstiti
lung
diseas
report
korea
knowledg
definit
mechan
sili
yet
known
howev
author
propos
potenti
toxic
mechan
might
mediat
intracellular
lipid
metabol
mitochondri
metabol
immunolog
respons
well
genet
predispos
factor
diagnosi
sili
gener
depend
relationship
caus
agent
clinic
symptom
well
radiolog
find
exclus
infecti
diseas
unclear
mechan
although
histopatholog
find
also
nondiagnost
base
prior
report
studi
possibl
diagnosi
significantli
increas
alveolar
macrophag
foami
appear
confirm
cytolog
along
patient
clinic
histori
furthermor
report
suggest
promin
featur
dild
bal
fluid
lymphocyt
alveol
either
pure
associ
neutrophil
andor
eosinophil
alveol
along
imbal
lymphocyt
phenotyp
case
infecti
diseas
exclud
base
neg
microbi
cultur
result
addit
patient
symptom
bilater
infiltr
began
start
rosuvastatin
reveal
chest
radiolog
alveolar
macrophag
final
foami
appear
reveal
cytolog
alveolar
macrophag
final
foami
appear
reveal
cytolog
increas
lymphocyt
eosinophil
cellular
profil
bal
fluid
thereaft
discontinu
rosuvastatin
initi
steroid
therapi
patient
symptom
radiolog
find
improv
therefor
knowledg
patient
first
diagnos
rosuvastatininduc
interstiti
lung
diseas
korea
compar
previou
case
taiwan
unit
state
clinic
cours
radiolog
find
cytolog
similar
case
also
perform
lung
biopsi
howev
increas
lymphocyt
eosinophil
along
predomin
macrophag
cellular
profil
bal
fluid
reveal
patient
believ
foami
macrophag
appear
could
help
diagnosi
sili
coupl
clinic
symptom
radiolog
find
clinician
consid
potenti
rosuvastatininduc
lung
injuri
